Phase
Condition
Depression (Major/severe)
Mood Disorders
Depression
Treatment
N/AClinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adult ambulatory patients diagnosed of bipolar disorder I or II, current depressiveepisode (DSM-IV-TR 4ª Ed: 296.5x or 296.89 codes)
Have been treated with only one mood stabilizer (lithium or valproate) in optimal andstable doses during at least the previous 4 weeks to randomization
Hamilton Depression Rating Scale (HDRS-17) total score ≥ 20 and Young Mania RatingScale (YMRS) total score ≤ 14 at the screening and randomization visits - Informedconsent signed
Exclusion
Exclusion Criteria:
Patients with any axis I or II Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR) diagnoses different from bipolar disorder I orII - Length of current depressive episode less than 2 weeks or more than 12 months
Having been treated with more than one mood stabilizer or any mood stabilizer otherthan Lithium or valproate, any antidepressant, any antipsychotic or any CP450-3Ainductor/inhibitor within the 7 days period prior to randomization
Study Design
Connect with a study center
Research Site
Santander, Cantabria
SpainSite Not Available
Research Site
Zamora, Castilla-León
SpainSite Not Available
Research Site
Vigo, Galicia
SpainSite Not Available
Research Site
Vitoria, Pais Vasco
SpainSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.